Skip to main content

Table 6 Pathological assessment of surgical specimens

From: Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study

Pathological assessment

Group 1

(n = 19)

Group 2

(n = 40)

P value

pCR (pT0N0), n (%)

5 (26.3)

1 (2.5)

0.018

Resection margins, n (%)

  

> 0.999

R0

19 (100)

39 (97.5)

 

R1

0

1 (2.5)

 

Pathologic T stage, n (%)

  

0.053

pT0

5(26.3)

1(2.5)

 

pT1

4 (21.1)

6 (15.0)

 

pT2

2 (10.5)

9 (22.5)

 

pT3

2 (10.5)

6 (15.0)

 

pT4

6 (31.6)

18 (45.0)

 

Pathologic N stage, n (%)

  

0.179

pN0

13 (68.4)

20 (50)

 

pN1

3 (15.8)

10 (25)

 

pN2

3 (15.8)

7 (17.5)

 

pN3

0

3 (7.5)

 

Pathologic stage, n (%)

  

0.892

I

4 (28.6)

10 (25.6)

 

II

1 (7.1)

3 (7.7)

 

IIIA

1 (7.1)

5 (12.8)

 

IIIB

5 (35.7)

11 (28.2)

 

IVA

3 (21.4)

10 (25.6)

 
  1. pCR, pathologic complete response; R0, no residual tumour tissue; R1, microscopic residual tumour tissue at the resection margin